Free Newsletters | Help  

  Current | By Company | NEW Products
Login ID:    Password:    Register for a FREE account
 NEWS

Industry News
Business
Organic
Food & Beverage
Sports Nutrition
Nutraceuticals
Regulatory
Research
Products
Practitioners
Retail
Events
People
On-line


 LISTINGS
  Categories
Products

Profiles
Publishers

 OPINION
  Editorials
Interviews
Up and Comers
Quality Initiatives

 
Blogs
Andrew Stewart  
Marc Ullman FYI Blog
Len Monheit Off The Cuff
James S. Tonkin - Formulating Beverages  
Jim Lassiter -- Good News/Bad News
The Nutrition Business Journal Blog

Join the NPIcenter LinkedIn Group Group
Join the Facebook page Page
Follow us on
Join the Facebook page


 FEATURES
 

Newsletter

  News Feeds
 
 SERVICES
  Log in
Register User
Add Company
Career Center
Advertise

 INFO CENTER
  Help
Contact Us
About NPI
Privacy Policy



 

Advertisement



Share Subscribe to NPIcenter Newsfeed

Ongoing List of EFSA NDA Panel Opinions
2009-10-28 - NPIcenter




EFSA NDA Opinions

 

 

Approved


Calcium + Vitamin D3 chewing tablets and bone loss - Scientific substantiation of a health claim related to Calcium plus Vitamin D3 chewing tablets and reduction of the risk of osteoporotic fractures by reducing bone loss pursuant to Article 14 of Regulation (EC) No 1924/2006 [1]

Published: 7 August 2009     Adopted: 2 July 2009

 

Lycopene-whey complex (bioavailable lycopene) and risk of atherosclerotic plaques Scientific substantiation of a health claim related to Lycopene-whey complex (bioavailable lycopene) and reduction of the risk of atherosclerotic plaques pursuant to Article 14 of Regulation (EC) No 1924/2006 [1]

Published: 3 August 2009     Adopted: 2 July 2009

 

Plant Stanols and Plant Sterols and Blood LDL-Cholesterol - Scientific Opinion of the Panel on Dietetic Products Nutrition and Allergies on a request from the European Commission and a similar request from France in relation to the authorization procedure for health claims on plant stanols and plant sterols and lowering/reducing blood LDL-cholesterol pursuant to Article 14 of Regulation (EC) No 1924/2006 [1]

Published: 31 July 2009     Adopted: 30 June 2009


Water-soluble tomato concentrate (WSTC I and II) and platelet aggregation - Water-soluble tomato concentrate (WSTC I and II) and platelet aggregation [1]

Published: 28 May 2009     Adopted: 15 May 2009

 

Lipil® and visual development - Scientific substantiation of a health claim related to Lipil® and visual development pursuant to Article14 of Regulation (EC) No 1924/2006[1]

Published: 23 March 2009     Adopted: 13 March 2009

 

Enfamil® Premium and visual development - Scientific substantiation of a health claim related to Enfamil® Premium and visual development pursuant to Article14 of Regulation (EC) No 1924/2006[1]

Published: 23 March 2009     Adopted: 13 March 2009

 

DHA and ARA and visual development - Scientific substantiation of a health claim related to docosahexaenoic acid (DHA) and arachidonic acid (ARA) and visual development pursuant to Article14 of Regulation (EC) No 1924/2006[1]

Published: 13 February 2009     Adopted: 22 January 2009

 

Safety of ‘Lipid extract from Euphausia superba' as a novel food ingredient Safety of ‘Lipid extract from Euphausia superba' as a novel food ingredient [1]

Published: 13 February 2009     Adopted: 22 January 2009

 

Animal protein and bone growth - Scientific substantiation of a health claim related to animal protein and bone growth pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 14 November 2008     Adopted: 31 October 2008

 

Plant stanol esters and blood cholesterol - Scientific substantiation of a health claim related to plant stanol esters and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 31 October 2008     Adopted: 2 October 2008

 

Calcium and bone growth - Scientific substantiation of a health claim related to calcium and bone growth pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 22 October 2008     Adopted: 2 October 2008

 

Calcium and vitamin D and bone strength - Scientific substantiation of a health claim related to calcium and vitamin D and bone strength pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 22 October 2008     Adopted: 2 October 2008

 

Vitamin D and bone growth - Scientific substantiation of a health claim related to vitamin D and bone growth pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 22 October 2008     Adopted: 2 October 2008

 

Plant Sterols and Blood Cholesterol - Scientific substantiation of a health claim related to plant sterols and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006[1]

Published: 21 August 2008     Adopted: 11 July 2008

 

 

Not Approved

Scientific Opinion on the substantiation of a health claim related to OPC Premium and the reduction of blood cholesterol pursuant to Article 14 of Regulation (EC) No 1924/2006 [1]

Published: 23 October 2009     Adopted: 15 October 2009

 

Regulat® and “the immune system” - Scientific substantiation of a health claim related to Regulat® and “enhancement/modulation/improvement/regulation of the activity of the immune system” pursuant to Article 13(5) of Regulation (EC) No 1924/2006 [1]

Published: 17 July 2009     Adopted: 2 July 2009


Gum Periobalance(TM) tablets and chewing gum and oral health - Scientific substantiation of a health claim related to Gum Periobalance™ tablets and chewing gum and oral health pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Published: 16 July 2009     Adopted: 2 July 2009

 

BimunoTM and help to maintain a healthy gastro-intestinal function - Scientific substantiation of a health claim related to BimunoTM and help to maintain a healthy gastro-intestinal function pursuant to Article 13(5) of Regulation (EC) No 1924/2006[1]

Published: 7 July 2009     Adopted: 15 May 2009

 

BimunoTM and support of the immune system - Scientific substantiation of a health claim related to BimunoTM and support of the immune system pursuant to Article 13(5) of Regulation (EC)[1]

Published: 7 July 2009     Adopted: 15 May 2009

 

BimunoTM and reduction of the bad bacteria that can cause travellers’ diarrhoea - Scientific substantiation of a health claim related to BimunoTM and reduction of the bad bacteria that can cause travellers’ diarrhoea pursuant to Article 14 of Regulation (EC) No 1924/2006[1]

Published: 7 July 2009     Adopted: 15 May 2009


Natural Push-Up® Tablets and Capsules and female breast-enhancement process - Scientific substantiation of a health claim related to a Natural Push-Up® Tablets and Capsules, and imitating the female breast-enhancement process pursuant to Article 13(5) of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 4 June 2009     Adopted: 15 May 2009

DHA and support of the visual development of the unborn child and breastfed infant - Scientific substantiation of a health claim related to DHA and support of the visual development of the unborn child and breastfed infant pursuant to Article 14 of Regulation (EC) No 1924/2006 [1]

Published: 15 April 2009     Adopted: 13 March 2009

 

DHA and support of the cognitive development of the unborn child and breastfed infant - Scientific substantiation of a health claim related to DHA and support of the cognitive development of the unborn child and breastfed infant pursuant to Article 14 of Regulation (EC) No 1924/2006 [1]

Published: 15 April 2009     Adopted: 13 March 2009

 

Lactobacillus plantarum 299v (DSM 9843) and improve iron absorption

- Scientific substantiation of a health claim related to Lactobacillus plantarum 299v (DSM 9843) and improve iron absorption pursuant to Article 13(5) of Regulation (EC) No 1924/2006 [1]

Published: 6 April 2009     Adopted: 13 March 2009

 

ALA and contribution to brain development - Scientific substantiation of a health claim related to ALA and contribution to brain development pursuant to Article 14 of Regulation (EC) No 1924/2006 [1]

Published: 3 April 2009     Adopted: 13 March 2009

 

DHA and ARA and brain development - Scientific substantiation of a health claim related to docosahexaenoic acid (DHA) and arachidonic acid (ARA) and brain development pursuant to Article14 of Regulation (EC) No 1924/2006[1]

Published: 23 March 2009     Adopted: 13 March 2009

 

Enfamil® Premium and brain development - Scientific substantiation of a health claim related to Enfamil® Premium and brain development pursuant to Article14 of Regulation (EC) No 1924/2006[1]

Published: 23 March 2009     Adopted: 13 March 2009

 

Lipil® and brain development - Scientific substantiation of a health claim related to Lipil® and brain development pursuant to Article14 of Regulation (EC) No 1924/2006[1]

Published: 23 March 2009     Adopted: 13 March 2009

 

Follow-on formulae with bioactive constituents and intestinal ailments - Scientific substantiation of a health claim related to “Follow-on formulae with fixed combination of short-chain galacto-oligosaccharides (GOS), acidified milk, nucleotides and beta-palmitate” and intestinal ailments pursuant to Article 14 of Regulation (EC) No 1924/2006[1]

Published: 13 March 2009     Adopted: 22 January 2009

 

Algatrium® and antioxidant response - Scientific substantiation of a health claim related to Algatrium® and antioxidant response Article 13(5) of Regulation (EC) No 1924/2006[1]

Published: 13 March 2009     Adopted: 22 January 2009

 

Melgaço mineral water and reduction of glycaemia - Scientific substantiation of a health claim related to Melgaço® mineral water and reduction of glycaemia pursuant to Article 14 of Regulation (EC) No 1924/2006[1]

Published: 13 February 2009     Adopted: 22 January 2009

 

Kinder Chocolate® and growth - Scientific substantiation of a health claim related to Kinder Chocolate® and growth pursuant to Article 14 of Regulation (EC) No 1924/2006 [1]

Published: 13 February 2009     Adopted: 22 January 2009

 

Ocean Spray Cranberry Products® and urinary tract infection in women - Scientific substantiation of a health claim related to Ocean Spray Cranberry Products® and urinary tract infection in women pursuant to Article 14 of Regulation (EC) No 1924/2006 [1]

Published: 13 February 2009     Adopted: 22 January 2009

 

Dairy fresh cheese and bone growth - Scientific substantiation of a health claim related to dairy fresh cheese and bone growth pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 15 January 2009     Adopted: 4 December 2008

 

Black tea from Camellia sinensis and helps to focus attention - Scientific substantiation of a health claim related to black tea from Camellia sinensis and helps to focus attention, pursuant to Article 13(5) of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 22 December 2008     Adopted: 4 December 2008

 

Mumomega® and central nervous system development - Scientific substantiation of a health claim related to Mumomega® and central nervous system development pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 19 December 2008     Adopted: 4 December 2008

 

Efalex® and coordination - Scientific substantiation of a health claim related to Efalex® and coordination pursuant to Article14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 19 December 2008     Adopted: 4 December 2008

 

Milk product, rich in fibre and protein, and reduction of the sense of hunger[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 19 December 2008     Adopted: 4 December 2008

 

Eye q® and concentration - Scientific substantiation of a health claim related to Eye q® and concentration pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 19 December 2008     Adopted: 4 December 2008

 

Efalex® and brain development and function - Scientific substantiation of a health claim related to Efalex® and brain development and function pursuant to Article14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 19 December 2008     Adopted: 4 December 2008

 

Efalex® and concentration - Scientific substantiation of a health claim related to Efalex® and concentration pursuant to Article14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 19 December 2008     Adopted: 4 December 2008

 

Efalex® and eye development and function - Scientific substantiation of a health claim related to Efalex® and eye development and function pursuant to Article14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 19 December 2008     Adopted: 4 December 2008

 

Eye q baby® and central nervous system development - Scientific substantiation of a health claim related to Eye q baby® and central nervous system development pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 19 December 2008     Adopted: 4 December 2008

 

Eye q® and brain functions - Scientific substantiation of a health claim related to Eye q® and brain functions pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 19 December 2008     Adopted: 4 December 2008

 

Dairy product enriched with milk peptide and magnesium and help to moderate signs of anxiety in mildly stress-sensitive adult[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 19 December 2008     Adopted: 4 December 2008

 

Efalex® and learning ability - Scientific substantiation of a health claim related to Efalex® and learning ability pursuant to Article14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 19 December 2008     Adopted: 4 December 2008

 

LACTORAL and improvement of the general immunity - Scientific substantiation of a health claim related to LACTORAL (a combination of three probiotic strains: Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium longum) and improvement of the general immunity pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 10 December 2008     Adopted: 28 October 2008

 

LACTORAL and normal functioning of the alimentary tract - Scientific substantiation of a health claim related to LACTORAL (a combination of three probiotic strains: Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium longum) and normal functioning of the alimentary tract pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 10 December 2008     Adopted: 28 October 2008

 

LACTORAL and living probiotic bacteria - Scientific substantiation of a health claim related to LACTORAL (a combination of three probiotic strains: Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium longum) and living probiotic bacteria, pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 10 December 2008     Adopted: 28 October 2008

 

LACTORAL and maintenance of natural intestinal microflora during travel - Scientific substantiation of a health claim related to LACTORAL (a combination of three probiotic strains: Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium longum) and maintenance of natural intestinal microflora during travel, pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 10 December 2008     Adopted: 28 October 2008

 

LACTORAL and building of the natural intestinal barrier - Scientific substantiation of a health claim related to LACTORAL (a combination of three probiotic strains: Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium longum) and building of the natural intestinal barrier pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 10 December 2008     Adopted: 28 October 2008

 

Xylitol chewing gum/pastilles and reduction of the risk of tooth decay - Scientific substantiation of a health claim related to xylitol chewing gum/pastilles and reduction the risk of tooth decay pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 14 November 2008     Adopted: 30 October 2008

 

LGG® MAX and gastro-intestinal discomfort - Scientific substantiation of a health claim related to LGG® MAX and reduction of gastro-intestinal discomfort pursuant to Article 13(5) of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 14 November 2008     Adopted: 30 October 2008

 

I omega kids®/Pufan 3 kids® and learning ability - Scientific substantiation of a health claim related to I omega kids®/Pufan 3 kids® and learning ability pursuant to Article14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 31 October 2008     Adopted: 24 October 2008

 

I omega kids®/Pufan 3 kids® and thinking capacity - Scientific substantiation of a health claim related to I omega kids®/Pufan 3 kids® and thinking capacity pursuant to Article14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 31 October 2008     Adopted: 24 October 2008

 

I omega kids®/Pufan 3 kids® and concentration - Scientific substantiation of a health claim related to I omega kids®/Pufan 3 kids® and concentration pursuant to Article14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 31 October 2008     Adopted: 24 October 2008

 

I omega kids®/Pufan 3 kids® and mental development - Scientific substantiation of a health claim related to I omega kids®/Pufan 3 kids® and mental development pursuant to Article14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 31 October 2008     Adopted: 24 October 2008

 

I omega kids®/Pufan 3 kids® and vision - Scientific substantiation of a health claim related to I omega kids®/Pufan 3 kids® and vision pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 22 October 2008     Adopted: 2 October 2008

 

I omega kids®/Pufan 3 kids® and calming - Scientific substantiation of a health claim related to I omega kids®/Pufan 3 kids® and calming pursuant to Article14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 22 October 2008     Adopted: 2 October 2008

 

SI omega kids®/Pufan 3 kids® and serenity - Scientific substantiation of a health claim related to I omega kids®/Pufan 3 kids® and serenity pursuant to Article14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 22 October 2008     Adopted: 2 October 2008

 

Regulat®.pro.kid BRAIN and mental and cognitive development of children - Scientific substantiation of a health claim related to regulat®.pro.kid BRAIN and mental and cognitive developments of children pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 22 October 2008     Adopted: 2 October 2008

 

Evolus® and reduce arterial stiffness - Scientific substantiation of a health claim related to Lactobacillus helveticus fermented Evolus® low-fat milk products and reduction of arterial stiffness pursuant to Article 14 of the Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 22 October 2008     Adopted: 2 October 2008

 

DHA and ARA and development of brain and eyes - Scientific substantiation of a health claim related to Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) and support of the neural development of the brain and eyes pursuant to Article 14 of Regulation (EC) No 1924/2006 [1]

Published: 25 September 2008     Adopted: 8 September 2008

 

regulat®.pro.kid IMMUN and immune system of children - Scientific substantiation of a health claim related to regulat®.pro.kid IMMUN and immune system of children during growth pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 21 August 2008     Adopted: 11 July 2008

 

ALA and LA and growth and development of children - Scientific substantiation of a health claim related to α-linolenic acid and linoleic acid and growth and development of children pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 21 August 2008     Adopted: 11 July 2008

 

Femarelle® and bone mineral density - Scientific substantiation of a health claim related to “Femarelle®” and “induces bone formation and increases bone mineral density reducing the risk for osteoporosis and other bone disorders” pursuant to Article 14 of the Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 21 August 2008     Adopted: 4 August 2008

 

Elancyl Global Silhouette® and regulation of body composition - Scientific substantiation of a health claim related to Elancyl Global Silhouette® and “regulation of body composition in people with light to moderate overweight” pursuant to Article 13(5) of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 21 August 2008     Adopted: 12 August 2008

 

NeOpuntia® and blood lipid parameters - Scientific substantiation of a health claim related to NeOpuntia® and improvement of blood lipid parameters associated with cardiovascular risk, especially HDL-cholesterol, pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 21 August 2008     Adopted: 13 August 2008

 

Dairy and dental health - Scientific substantiation of a health claim pursuant related to dairy products (milk and cheese) and dental health to Article 14 of Regulation (EC)[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 21 August 2008     Adopted: 12 August 2008

 

Dairy foods and healthy body weight - Scientific substantiation of a health claim related to dairy foods and healthy body weight pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Published: 21 August 2008     Adopted: 8 August 2008

Related Articles :

  • The EFSA NDA Panel Shows Promise Amongst Negative Opinions (2008-09-25)
    An article discussing the recent EFSA NDA panel opinions in Europe. With commentary from Cantox's Nigel Baldwin and ESA's Stefanie Geiser.
  •  

    Advertisement



    Sponsored Links: Featured Links:
     

    NPIcenter Address and Phone Number
    Contact Us | Privacy Policy | Terms of Use | Advertise
    New Hope Natural Media

     

    SUPPLYEXPO Funtional Foods & Nutraceuticals Magazine Healthy Foods Conferences The Newport Summit - Executive Retreat Nutracon